A clinical decision guide for women in perimenopause who are weighing whether to start HRT. Covers the symptoms that signal readiness, what the research says about timing, who benefits most, what's changed since the WHI study, and how to walk into a provider appointment prepared, including what hormone data to bring.

A clinical decision guide for women in perimenopause who are weighing whether to start HRT. Covers the symptoms that signal readiness, what the research says about timing, who benefits most, what's changed since the WHI study, and how to walk into a provider appointment prepared, including what hormone data to bring.
You've been dealing with it for months, maybe years. The sleep that never feels restorative. The heat that wakes you at 3am. The mood that isn't yours. The brain that stalls mid-sentence. You've been told you're "too young," that your labs look fine, that you should try yoga or antidepressants or just wait it out.
And now you're asking the question that brings most women to this page: Is it time to start HRT?
This guide won't make that decision for you, that belongs to you and your provider. But it will give you what you actually need to make it: a clear picture of what the research says, the specific signals that suggest it's time, what's changed about HRT safety in the past few years, and how to walk into your next appointment prepared.
First: Why This Decision Feels So Hard
The confusion around HRT is not your fault. For more than two decades, a deeply flawed interpretation of the Women's Health Initiative (WHI) study caused providers to withhold or delay HRT from women who would have clearly benefited from it. The study's headline findings, linking HRT to increased breast cancer and cardiovascular risk, were applied to the wrong population. The WHI studied older women, most of whom were postmenopausal, many of whom were already at elevated cardiovascular risk, using a synthetic oral progestin. Those findings were then generalized to all women, including the 40-somethings actively in perimenopause who represent HRT's best candidates.
In November 2025, the FDA removed the black box warning that had sat on HRT labeling for 22 years, a formal acknowledgment that the evidence had shifted. As Oova's own coverage of that moment noted, the science behind HRT has been rewritten, and starting treatment during perimenopause, rather than waiting, is now understood to be the point of maximum benefit.
That context matters, because many women asking "is it time?" are actually asking "is it finally safe?" The answer, for most healthy women in perimenopause, is yes.
What HRT Actually Does
Hormone replacement therapy, typically transdermal estradiol plus progesterone for women with a uterus, works by restoring the hormonal levels your body is no longer maintaining reliably. In perimenopause, estrogen and progesterone don't decline smoothly. They crash, spike, and fluctuate unpredictably, sometimes dramatically within a single cycle. HRT doesn't eliminate that variability entirely, but it establishes a floor, a baseline that keeps your body from dropping into the low-estrogen state that drives the most debilitating symptoms.
Beyond symptom relief, earlier initiation of HRT is associated with meaningful long-term benefits: preserved bone density, reduced cardiovascular risk, lower rates of cognitive decline, and better metabolic function. The "timing hypothesis", the idea that HRT is most protective when started close to the onset of the menopausal transition rather than years later, is now supported by substantial evidence. Waiting is not neutral.
7 Signs It May Be Time to Consider HRT
No single symptom is a threshold, and not everyone with perimenopause symptoms needs HRT. But when several of the following are present, significantly impacting quality of life, and not improving with lifestyle changes alone, it is worth having a direct conversation with your provider.
1. Sleep disruption you can't explain otherwise Night sweats are the obvious culprit, but many women describe waking at 2–4am without sweating, just wired and unable to return to sleep. When sleep disruption is hormonal, it is driven by estrogen's role in regulating core body temperature and REM architecture. If you've ruled out sleep apnea, stress, and caffeine, and the pattern correlates with your cycle or started in your early 40s, estrogen is a strong candidate.
2. Hot flashes that interrupt your life A mild flush once a day is different from five flashes that soak through your shirt. Vasomotor symptoms, hot flashes and night sweats, are among the most well-studied indications for HRT, with the highest quality evidence behind them. If yours are frequent, intense, or disruptive enough to affect work or social functioning, that meets the clinical bar for treatment.
3. Mood changes that don't respond to what worked before New-onset anxiety in your 40s, a hair-trigger irritability that surprises you, or a low-grade flatness that isn't quite depression, these are estrogen-mediated. Estrogen has direct effects on serotonin, dopamine, and GABA signaling. If you've been offered antidepressants for these symptoms but you suspect it's hormonal, you're likely right. Nearly 40% of perimenopausal women are misdiagnosed, often with depression, when the underlying driver is estrogen fluctuation.
4. Brain fog that has changed your performance Not the occasional distraction, but a consistent dulling. Words that don't come. Tasks that take twice as long. A sense that your cognitive baseline has shifted. Estrogen supports cerebral blood flow and neuronal function; its decline during perimenopause is directly associated with the cognitive symptoms women describe. This is worth treating, not waiting out.
5. Vaginal and urinary symptoms Genitourinary syndrome of menopause, dryness, pain during sex, increased urinary urgency or recurrent UTIs, doesn't resolve on its own, and it progresses without treatment. If these symptoms are present, they are a strong signal that your local estrogen levels have dropped significantly, even if your systemic symptoms feel manageable.
6. Symptoms that have persisted for more than 6 months One bad month can be stress, illness, or a difficult cycle. Six months of consistently disrupted sleep, mood instability, and hot flashes is a pattern, and patterns in perimenopause reflect underlying hormonal change, not temporary fluctuation. If your symptoms have lasted this long and aren't improving, that is a reasonable clinical threshold for a treatment conversation.
7. You've tried lifestyle changes and they're not enough Exercise, reduced alcohol, improved sleep hygiene, stress management, all of these have supporting evidence and are worth doing regardless of whether you start HRT. But if you've implemented them consistently and are still experiencing significant symptoms, they are not a substitute for hormone therapy. They are complementary to it.
Not sure which symptoms are hormonal? Oova tracks your estrogen, progesterone, and LH daily so you can see exactly which hormones correlate with your worst days, and bring that data to your provider appointment. Start Tracking My Hormones →
What the Research Says About Timing
The most important thing the current evidence tells us is that earlier is generally better, not earlier in your day, but earlier in the transition. Starting HRT in perimenopause, before the final menstrual period, or within ten years of menopause onset, is associated with the most robust long-term benefits for bone, cardiovascular health, and cognitive protection. Women who begin HRT more than ten years after menopause do not appear to receive the same cardiovascular benefit and may face higher risk.
This is why "wait and see", a still-common provider recommendation, carries real costs. Waiting for symptoms to become unbearable is not a neutral strategy when it means delaying treatment past the window of maximum benefit. If you have been told to wait until your symptoms are worse, it is worth asking your provider directly about the timing evidence.
There is also no clinical requirement to confirm menopause before starting HRT. Perimenopause itself, defined by the STRAW+10 staging criteria as the years of hormonal variability preceding the final menstrual period, is an appropriate treatment window. You do not need to have stopped having periods.
Who HRT Is Not Right For
HRT is not appropriate for everyone, and this guide cannot replace individualized clinical assessment. HRT is generally contraindicated or requires careful risk-benefit evaluation for women with:
- A personal history of hormone receptor-positive breast cancer
- A history of blood clots (DVT or PE), particularly without a reversible cause
- Unexplained vaginal bleeding
- Active liver disease
- Certain cardiovascular conditions (discuss with your provider)
If you have any of these in your history, the conversation with your provider is still worth having, options exist, including non-hormonal therapies and low-dose local estrogen, but the decision requires individual assessment that this guide cannot provide.
The Problem With "Your Labs Are Normal"
One of the most common reasons women delay starting HRT is being told that their hormone labs came back normal. This is genuinely misleading, and it is worth understanding why.
Standard bloodwork, a one-time FSH or estradiol draw, captures a single point in time. In perimenopause, hormones fluctuate enormously across a cycle and from cycle to cycle. A woman whose estradiol ranges from 30 to 280 pg/mL in a single month might have her blood drawn on a day when the reading is 150, squarely in the "normal" range, and be told nothing is wrong.
This is what standard hormone tests actually miss about perimenopause: not the average value, but the pattern of variability that drives symptoms. The woman who crashes from 200 to 40 in a week feels that crash. A single blood draw on a mid-range day does not capture it.
If you've been dismissed because your labs look fine but you are clearly symptomatic, that dismissal is based on a fundamental limitation of snapshot testing, not a reflection of your hormonal reality.
What to Bring to Your Appointment
The most effective way to turn a "let's wait and see" appointment into a treatment conversation is to arrive with data your provider cannot dismiss. That means documentation of your symptoms over time, ideally correlated with your hormone pattern, not just a verbal description of how you've been feeling.
Specifically, tracking that shows:
- How your estradiol and progesterone move across your cycle
- The days your symptoms are worst, and what your hormone levels look like on those days
- Whether your LH is elevated or erratic, which helps support a perimenopause staging conversation
- How long your symptoms have been present and their frequency and severity
When your provider can see that your estradiol drops significantly in the late luteal phase and you reliably have your worst nights' sleep in that window, you have moved from "I've been feeling off" to a documentable hormonal pattern. That's a different conversation.
What Happens After You Start
If you and your provider decide to begin HRT, it helps to know what to actually expect, because the timeline is not instant, and many women abandon treatment in the first weeks because the relief takes longer than they anticipated.
Different symptoms respond at different rates. Hot flashes often begin to improve within two to four weeks. Sleep can take four to eight weeks to meaningfully stabilize. Mood, cognition, and vaginal symptoms may take longer still. Our week-by-week guide to what happens after starting HRT walks through exactly what to expect at each stage.
Getting the dose right is also rarely a first-attempt success. Most women require at least one adjustment in the first three to six months. Knowing the signs that your HRT dose needs recalibration, persistent symptoms, new side effects, or symptoms that improved then returned, means you can flag them early rather than assuming HRT isn't working. If symptoms did improve and then came back, that warrants its own investigation: why HRT stops working covers the most common reasons.
Understanding how your delivery method affects absorption, and the difference between patches, gels, creams, and oral options, also matters for getting to the right dose faster.
And for context on what your hormone levels should actually look like once you're on treatment, our first 90 days of HRT guide gives you target ranges and a realistic timeline for stabilization.
Already started HRT but not sure it's working? Track your daily estradiol and progesterone with Oova to see whether your levels are reaching the therapeutic range, and bring real data to your next dose conversation. Get the Oova Perimenopause Kit →
The Decision, Summarized
HRT is not the right answer for everyone. But for the majority of healthy women in perimenopause with symptoms that are interfering with quality of life, the evidence is clear: starting earlier is better than waiting, the risks have been significantly overstated for decades, and the potential benefits, both for symptom relief and long-term health, are substantial.
If you've been waiting for your symptoms to get bad enough, waiting for your labs to confirm what you already know, or waiting for a provider who takes your experience seriously, you don't have to keep waiting.
The decision is yours. Make it with data.
Not sure yet where you are in the transition? Oova tracks your hormones daily, with lab-grade accuracy, no needles, and results in under 10 minutes. FSA/HSA eligible. Start Tracking →
About the author

Sources
- Manson JE, et al. "Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality." JAMA. 2017;318(10):927–938.
- Harlow SD, et al. "Executive Summary of the Stages of Reproductive Aging Workshop +10 (STRAW+10)." Journal of Clinical Endocrinology & Metabolism. 2012;97(4):1159–1168.
- Stuenkel CA, et al. "Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline." Journal of Clinical Endocrinology & Metabolism. 2015;100(11):3975–4011.
- The NAMS 2022 Hormone Therapy Position Statement Advisory Panel. "The 2022 Hormone Therapy Position Statement of The Menopause Society." Menopause. 2022;29(7):767–794.
- Baber RJ, Panay N, Fenton A; IMS Writing Group. "2016 IMS Recommendations on Women's Midlife Health and Menopause Hormone Therapy." Climacteric. 2016;19(2):109–150.
- Lobo RA, et al. "Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause." Atherosclerosis. 2016;254:282–290. (Timing hypothesis / cardiovascular window.)
- Thurston RC, et al. "Vasomotor symptoms and menopause: findings from the Study of Women's Health Across the Nation." Obstetrics and Gynecology Clinics of North America. 2011;38(3):489–501.
- U.S. Food and Drug Administration. Removal of Black Box Warning from Hormone Therapy Labeling. November 2025.
About the Oova Blog:
Our content is developed with a commitment to high editorial standards and reliability. We prioritize referencing reputable sources and sharing where our insights come from. The Oova Blog is intended for informational purposes only and is never a substitute for professional medical advice. Always consult a healthcare provider before making any health decisions.

.png)
